Investigation of renal tolerability, efficacy and safety of a CNI-free regimen versus a low-dose CNI- regimen in de novo heart transplant recipients

Mise à jour : Il y a 4 ans
Référence : EUCTR2007-002671-14

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective of this trial is to demonstrate superiority of a CNI-free regimen with respect to the renal function at Month 18 post Tx assessed by glomerular filtration rate – MDRD method – as compared to a low dose CNI-based regimen in de novo heart transplant patients.


Critère d'inclusion

  • Heart Transplantation

Liens